Filter Results :

Your search for Neural returned 33 reports

Sort by


Postherpetic Neuralgia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Postherpetic Neuralgia-API Insights, 2015,report provides Postherpetic Neuralgia drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by...

$ 1,250.00

Read More

Neuralgia-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
SUMMARYDelveInsight’s, “ Neuralgia-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this Neuralgia. A key objective of DelveInsight’s report is to establish the understanding for all the pipeline drugs that fall under Neuralgia. The report provides infor...

$ 1,250.00

Read More

Postherpetic Neuralgia-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
SUMMARYDelveInsight’s, “ Postherpetic Neuralgia-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this Postherpetic Neuralgia. A key objective of DelveInsight’s report is to establish the understanding for all the pipeline drugs that fall under Postherpet...

$ 1,250.00

Read More

Acute Sensorineural Hearing Loss-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
SUMMARYDelveInsight’s, “ Acute Sensorineural Hearing Loss-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this Acute Sensorineural Hearing Loss. A key objective of DelveInsight’s report is to establish the understanding for all the pipeline drugs that fa...

$ 1,250.00

Read More

Global Neural Navigation System Industry 2015 Market Research Report

10 Mar 2015  |  Published by:  9Dimen Research
2015 Global Neural Navigation System Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Neural Navigation System industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, ...

$ 2,850.00

Read More

Neuralstem, Inc. (CUR) - Financial and Strategic SWOT Analysis Review

04 Mar 2015  |  Published by:  GlobalData
SummaryNeuralstem, Inc. (Neuralstem) is a pharmaceutical company. The company develops and markets medicines based on human neural stem cell technology and cell therapy. It provides cell therapy treatment for ALS, ischemic stroke, spinal cord injury, glioblastoma, multiple sclerosis, optic neuritis,...

$ 300.00

Read More

Trigeminal Neuralgia - Pipeline Review, H1 2015

10 Feb 2015  |  Published by:  Global Markets Direct
Summary‘Trigeminal Neuralgia - Pipeline Review, H1 2015’, provides an overview of the Trigeminal Neuralgia’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Trigeminal Neuralgia, complete with comparative analysis at various stages, therapeutics...

$ 2,000.00

Read More

Acute Sensorineural Hearing Loss - Pipeline Review, H1 2015

22 Jan 2015  |  Published by:  Global Markets Direct
Summary‘Acute Sensorineural Hearing Loss - Pipeline Review, H1 2015’, provides an overview of the Acute Sensorineural Hearing Loss’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Acute Sensorineural Hearing Loss, complete with comparative anal...

$ 2,000.00

Read More

Neuralstem, Inc. (CUR) - Medical Equipment - Deals and Alliances Profile

20 Jan 2015  |  Published by:  GlobalData
SummaryNeuralstem, Inc. (Neuralstem) is a pharmaceutical company. The company develops and markets medicines based on human neural stem cell technology and cell therapy. It provides cell therapy treatment for ALS, ischemic stroke, spinal cord injury, glioblastoma, multiple sclerosis, optic neuritis,...

$ 250.00

Read More

Acute Sensorineural Hearing Loss - Pipeline Review, H2 2014

31 Dec 2014  |  Published by:  Global Markets Direct
Summary ‘Acute Sensorineural Hearing Loss - Pipeline Review, H2 2014’, provides an overview of the Acute Sensorineural Hearing Loss’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Acute Sensorineural Hearing Loss, complete with comparative ana...

$ 2,000.00

Read More

Trigeminal Neuralgia - Pipeline Review, H2 2014

31 Dec 2014  |  Published by:  Global Markets Direct
Summary ‘Trigeminal Neuralgia - Pipeline Review, H2 2014’, provides an overview of the Trigeminal Neuralgia’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Trigeminal Neuralgia, complete with comparative analysis at various stages, therapeutic...

$ 2,000.00

Read More

Neuralstem, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

25 Nov 2014  |  Published by:  GlobalData
SummaryNeuralstem, Inc. (Neuralstem) is a pharmaceutical company. The company develops and markets medicines based on human neural stem cell technology and cell therapy. It provides cell therapy treatment for ALS, ischemic stroke, spinal cord injury, glioblastoma, multiple sclerosis, optic neuritis,...

$ 250.00

Read More

Sredneural'skiy medeplavil'nyi zavod (SUMZ) - Company Capsule

14 Nov 2014  |  Published by:  World Market Intelligence
Synopsis"Sredneural'skiy medeplavil'nyi zavod (SUMZ) - Company Capsule" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, financial ratios, financial analysis, key employees.SummaryThis report...

$ 75.00

Read More

Neuralgia Partnering 2009-2014

01 Nov 2014  |  Published by:  CurrentPartnering
The Neuralgia Partnering 2009-2014 provides understanding and access to the neuralgia partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of neuralgia partnering deals. The majority of deals are discovery or development st...

$ 695.00

Read More

Postherpetic Neuralgia - Pipeline Review, H2 2014

31 Aug 2014  |  Published by:  Global Markets Direct
Summary‘Postherpetic Neuralgia - Pipeline Review, H2 2014’, provides an overview of the Postherpetic Neuralgia’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Postherpetic Neuralgia, complete with comparative analysis at various stages, therap...

$ 2,000.00

Read More
Total 33 records.